Dimensional Fund Advisors’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLRX
BCM
Dimensional Fund Advisors's PLRX Position: Q3 2026 in Review
Dimensional Fund Advisors reduced its Pliant Therapeutics (PLRX) stake by 9.9% in Q3 2026, selling an estimated $11K and leaving 89,877 shares worth $97.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3133.
Dimensional Fund Advisors first reported a position in PLRX in Q1 2022 and has held it in 18 quarters since. The position peaked at $7.21M in Q4 2024. 15 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.
- Dimensional Fund Advisors held 89,877 shares of Pliant Therapeutics worth $97.1K as of Q3 2026.
- Dimensional Fund Advisors sold 9,896 Pliant Therapeutics shares in Q3 2026, an estimated $11K.
- Pliant Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #3133 holding.
- Dimensional Fund Advisors first reported a position in Pliant Therapeutics in Q1 2022 and has held it in 18 quarters since.
- Dimensional Fund Advisors's Pliant Therapeutics position peaked at $7.21M in Q4 2024.
- 15 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.